Michael Marino Net Worth

The estimated Net Worth of Michael F Iii Marino is at least $1.8 Milhão dollars as of 17 July 2024. Mr. Marino owns over 49,408 units of OptiNose Inc stock worth over $506,427 and over the last 9 years he sold OPTN stock worth over $200,051. In addition, he makes $1,090,070 as Chief Legal Officer and Corporate Secretary at OptiNose Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Marino OPTN stock SEC Form 4 insiders trading

Michael has made over 20 trades of the OptiNose Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 49,408 units of OPTN stock worth $56,325 on 17 July 2024.

The largest trade he's ever made was selling 49,408 units of OptiNose Inc stock on 17 July 2024 worth over $56,325. On average, Michael trades about 4,247 units every 48 days since 2015. As of 17 July 2024 he still owns at least 550,464 units of OptiNose Inc stock.

You can see the complete history of Mr. Marino stock trades at the bottom of the page.

Michael Marino biography

Michael F. Marino III, J.D. serves as Chief Legal Officer and Corporate Secretary of the Company. Mr. Marino has served as our Chief Legal Officer and Corporate Secretary since January 2017 and as a member of the board of directors of OptiNose AS since June 2018. Prior to joining Optinose, Mr. Marino served as Senior Vice President, General Counsel and Corporate Secretary of Fibrocell Science, Inc., a publicly-traded cell and gene therapy company, from June 2015 to January 2017. Prior to joining Fibrocell Science, Mr. Marino served as Senior Vice President, General Counsel and Corporate Secretary of NuPathe Inc., a publicly-traded specialty pharmaceutical company from October 2010 until the sale of NuPathe to Teva Pharmaceutical Industries Ltd. in March 2014 and from March 2014 to June 2015 as a legal consultant in the life sciences industry. Mr. Marino was previously an attorney at the law firms of Morgan, Lewis & Bockius LLP and WilmerHale LLP where his practice focused on mergers and acquisitions, collaborations, financing transactions, corporate governance, securities and other general corporate matters. Mr. Marino earned a B.S. in Accountancy from Villanova University and a J.D. from Boston College Law School.

What is the salary of Michael Marino?

As the Chief Legal Officer and Corporate Secretary of OptiNose Inc, the total compensation of Michael Marino at OptiNose Inc is $1,090,070. There are 2 executives at OptiNose Inc getting paid more, with Peter Miller having the highest compensation of $2,033,500.

How old is Michael Marino?

Michael Marino is 44, he's been the Chief Legal Officer and Corporate Secretary of OptiNose Inc since 2017. There are 16 older and no younger executives at OptiNose Inc. The oldest executive at OptiNose Inc is Sandra Helton, 70, who is the Independent Director.

What's Michael Marino's mailing address?

Michael's mailing address filed with the SEC is C/O OPTINOSE, INC., 777 TOWNSHIP LINE ROAD, SUITE 300, YARDLEY, PA, 19067.

Insiders trading at OptiNose Inc

Over the last 19 years, insiders at OptiNose Inc have traded over $144,654,703 worth of OptiNose Inc stock and bought 116,688 units worth $814,936 . The most active insiders traders include Sriram Venkataraman, Capital Partners Ii Gp, Llc..., eRajat Rai. On average, OptiNose Inc executives and independent directors trade stock every 26 days with the average trade being worth of $106,645. The most recent stock trade was executed by Anthony J Krick on 17 July 2024, trading 6,845 units of OPTN stock currently worth $7,803.

What does OptiNose Inc do?

optinose, inc., established in 2010 and headquartered in yardley, pennsylvania, is a publicly traded, global specialty pharmaceutical company focused on serving the needs of patients cared for by ent and allergy specialists. our team of kind, passionate, innovative people is building a new kind of organization without the encumbrances of a company with legacy systems and beliefs. we are unified by a shared mission: to improve lives. we do this while also creating great value for the healthcare system and great outcomes for our stakeholders. as innovators in every aspect of our work, we pursue faster and less costly product development, explore evolving commercial business models, and actively seek innovative ways to be more effective and efficient in all areas of the business. we operate with an overarching commitment to doing what is right. we are committed to working together as a team that chooses to live every day by core company values that guide our daily behaviors, creating a fo

Complete history of Mr. Marino stock trades at OptiNose Inc

OptiNose Inc executives and stock owners

OptiNose Inc executives and other stock owners filed with the SEC include:

• Peter Miller,
  Chief Executive Officer, Director
• Ramy Mahmoud,
  President, Chief Operating Officer
• Michael Marino,
  Chief Legal Officer and Corporate Secretary
• Peter K. Miller,
  CEO & Director
• Keith Goldan,
  Chief Financial Officer
• Dr. Ramy A. Mahmoud M.D., M.P.H.,
  Pres & COO
• Michael F. Marino,
  Chief Legal Officer & Corp. Sec.
• Keith Alan Goldan,
  Chief Financial Officer
• Victor M. Clavelli,
  Chief Commercial Officer
• Michael F. Marino Esq.,
  Chief Legal Officer & Corp. Sec.
• Joseph Scodari,
  Independent Chairman of the Board
• Sandra Helton,
  Independent Director
• Wilhelmus Groenhuysen,
  Independent Director
• William Doyle,
  Independent Director
• Jonathan Neely,
  VP Investor Relations and Business Operations
• Catherine Owen,
  Director
• Victor Clavelli,
  Chief Commercial Officer
• Anthony Krick,
  VP & Chief Accounting Officer
• Michele Janis MBA,
  VP & Acting CFO
• Dr. Per Gisle Djupesland M.D., Ph.D.,
  Co-Founder & Chief Scientific Officer of OptiNose AS
• Helena Kyttari Djupesland,
  Co-Founder of Optinose AS (Norway) & Co-CEO of Optinose AS (Norway)
• John Messina,
  Sr. VP of Clinical Devel. & Medical Affairs
• Karen E. Brophy,
  VP of HR
• Paul Mastrapa,
  CFO
• John N Kapoor,
  Director
• Edward A Blechschmidt,
  Director
• Leo Henikoff,
  Director
• Kenneth Abramowitz,
  Director
• Jerome Sheldon,
  Director
• Rajat Rai,
  CEO
• Joseph Bonaccorsi,
  Secretary
• Richard M Smith,
  President & COO
• Capital Partners Ii Gp, Llc...,
  
• Ventures Llctkwd Ventures L...,
  
• Fund Lp Entrepreneurs Fund ...,
  
• Rick Bierly,
  Director
• Sriram Venkataraman,
  Director
• Larry G Pickering,
  Director
• Thomas Edward Gibbs,
  Chief Commercial Officer
• Joshua Alexander Tamaroff,
  Director
• Robert P O'neil,
  Director
• Ventures Llc Wfd,
  10% owner
• Ventures Llc Tkwd,
  10% owner
• Anthony J Krick,
  Chief Accounting Officer
• Tomas J. Heyman,
  Director
• Kyle Dempsey,
  Director
• Eric Bednarski,
  Director
• R John Fletcher,
  Director
• Paul Jr. Spence,
  Chief Commercial Officer
• Michele Janis,
  Acting Chief Financial Officer